Dongwha Pharm Co Ltd banner

Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 5 910 KRW 0.17%
Market Cap: ₩165.1B

Profitability Summary

Dongwha Pharm Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Dongwha Pharm Co Ltd

Margins Comparison
Dongwha Pharm Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Dongwha Pharm Co Ltd
KRX:000020
163.8B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
871.6B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.4B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296.9B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
89.3B GBP
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Dongwha Pharm Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Dongwha Pharm Co Ltd
KRX:000020
163.8B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
871.6B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296.9B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
Loading...
UK
GlaxoSmithKline PLC
LSE:GSK
89.3B GBP
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Dongwha Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett